Table 4. Clinical outcomes of HAP patients in the overall cohort before PSM.
| Variables | Total (N = 631) | Monotherapy (n = 345) | Combination therapy (n = 286) | P value | |
|---|---|---|---|---|---|
| 30-day mortality | 110 (17.4) | 58 (16.8) | 52 (18.2) | 0.729 | |
| 90-day mortality | 153 (24.2) | 87 (25.2) | 66 (23.1) | 0.595 | |
| Hospital mortality | 161 (25.5) | 90 (26.1) | 71 (24.8) | 0.787 | |
| ICU admission | 138 (21.9) | 66 (19.1) | 72 (25.2) | 0.083 | |
| ICU length of stay, days | 16.2 ± 16.5 | 16.8 ± 17.3 | 15.7 ± 15.8 | 0.706 | |
| Hospital length of stay, days | 44.2 ± 48.8 | 46.2 ± 53.2 | 41.9 ± 42.9 | 0.278 | |
| Clinical responses | 0.699 | ||||
| Clinical cure | 453 (71.8) | 245 (71.0) | 208 (72.7) | ||
| Clinical failure or recurrence | 178 (28.2) | 100 (29.0) | 78 (27.3) | ||
| Destination | n = 470 | n = 255 | n = 215 | 0.061 | |
| Home | 270 (57.4) | 136 (53.3) | 134 (62.3) | ||
| Transfer to step-down facility | 200 (42.6) | 119 (46.7) | 81 (37.7) | ||
Values are presented as mean ± standard deviation or number (%).
HAP = hospital-acquired pneumonia, PSM = propensity score matching, ICU = intensive care unit.